HML Metropolis
Heath
and Disease are Triggered by the Human Immune System.
Thus
molecular understanding of
basic homeostatic mechanisms in immunology, biochemistry and physiology is essential
for the development of innovative
drug development and disease preventing or detecting technologies.
Novel
biomedical technologies
such as emerging proteomics support molecular networks analysis, biomarker development,
diagnostics and hypothesis &
experimental driven drug targeting in translational and personalized medicine.
Applying
cutting edge, next-generation medical biotechnologies, such as qualitative and
quantitative mass spectrometry,
including bioinformatics and
systems biology combined with preclinical expert
knowledge and interdisciplinary
skills will
allow us to develop iteratively new
concepts, new assays and therapeutic strategies further.
|
IMMUNO |
TECHNOLOGY |
KNOWLEDGE |
EDUCATIONAL TRAINING |
Copyright & Contact:
Institute for Immunoproteomics
Heidelberg-Mannheim